MECP2 and Rett syndrome: The impairment of the Wnt/β-catenin pathway could be correlated to decreased levels of MeCP2 SUMOylation observed for most of the mutations associated with RTT (i.e. R106W, R133C, P152A, T158M, R306C and P376R).